ENGNWenGene Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of enGene Therapeutics Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENGNWEsta | $15M#7 | 0.1x#1 | 0.1x#1 | — | — | -112.7%#9 | — | -50.9%#3 | — | — | -89.4%#10 | — |
| BSEM | $22M#1 | — | 0.8x#2 | 0.5x#1 | -31.8%#3 | -121.2%#10 | -1.5%#1 | -23.8%#2 | — | — | — | — |
| ESLA | $21M#2 | — | — | — | — | — | — | — | — | — | -80.3%#8 | — |
| BKHA | $20M#3 | — | — | — | — | -30.6%#8 | — | — | — | — | 48.0%#1 | 260.2%#1 |
| JSPR | $18M#4 | — | 12.7x#6 | — | — | 100.0%#1 | — | -0.0%#1 | — | — | -76.1%#7 | — |
| SCLX | $16M#5 | — | — | 0.5x#2 | -46.5%#4 | -413.8%#11 | -1143.7%#3 | — | — | 4#1 | -82.5%#9 | — |
| PLUR | $15M#6 | — | — | 15.1x#4 | -24.0%#2 | -5.5%#6 | -2454.5%#4 | — | — | — | -68.9%#6 | — |
| DYAI | $15M#8 | — | — | 4.7x#3 | -11.6%#1 | -26.8%#7 | -232.8%#2 | — | — | — | -65.1%#5 | — |
| BCDA | $13M#9 | — | 4.9x#5 | — | -100.0%#5 | -3.5%#5 | — | -304.7%#5 | — | — | -37.6%#3 | — |
| BCLI | $13M#10 | — | — | — | — | 11.3%#4 | — | — | — | — | -1.7%#2 | — |
| PASG | $12M#11 | — | 2.6x#4 | — | — | 29.7%#2 | — | -1021.6%#6 | — | — | -48.7%#4 | — |
| INTS | $11M#12 | — | 1.2x#3 | — | — | 28.7%#3 | — | -126.0%#4 | — | — | -89.9%#11 | — |
| CERO | $7M#13 | — | — | — | — | — | — | — | — | — | -94.4%#12 | 1.8%#2 |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice